Fig. 6 | Scientific Reports

Fig. 6

From: Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients

Fig. 6

Correlation between RBD-ACE2 blocking and anti-spike antibody levels on day 14 in patients with COVID-19. Blocking antibodies were detected by the sVNT assay30, whereas anti-spike antibodies were measured using the Elecsys® anti-spike assay. The pairwise correlation coefficient (r) was determined using Spearman’s rank correlation.

Back to article page